Ö. Ataman

Failure-specific prognostic factors after continuous hyperfractionated accelerated radiotherapy (CHART) or conventional radiotherapy in locally advanced non-small-cell lung cancer: A competing risks analysis

S. Dische, S. Bentzen, M. Saunders, 2001, British Journal of Cancer.

First-in-human phase I study of immunomodulatory E7046, an antagonist of PGE2-receptor E-type 4 (EP4), in patients with advanced cancers

G. Shapiro, F. Meric-Bernstam, A. Naing, 2020, Journal for immunotherapy of cancer.

Treatment results of definitive radiotherapy in 144 early stage larynx carcinoma

M. Kinay, F. Akman, A. Ömer, 2006 .

Planning Posttherapeutic Oncology Surveillance Visits Based on Individual Risk

A. Barrett, A. Kramar, T. Filleron, 2009, Medical decision making : an international journal of the Society for Medical Decision Making.